Liminatus Pharma, Inc. Warrants (LIMNW) is a publicly traded BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector company. As of August 21, 2026, LIMNW trades at $0.12 with a market cap of $0 and a P/E ratio of 0.00. LIMNW moved -0.73% today. Year to date, LIMNW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces LIMNW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Liminatus Pharma, Inc. Warrants (LIMNW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LIMNW moved -0.73% today.
| Metric | Value |
|---|---|
| Price | $0.12 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 240.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
LIMNW analyst coverage data. Average price target: $0.00.